VIVANI MED.INC. NEW O.N. Cash Flow-to-Debt Ratio
VIVANI MED.INC. NEW O.N. cash flow-to-debt ratio. VIVANI MED.INC. NEW O.N. (U5P) has a Cash Flow-to-Debt Ratio of -0.28x as of December 2025, meaning its operating cash flow of €-6.72 Million could theoretically repay 0% of its total liabilities (€23.66 Million) in one year. See VIVANI MED.INC. NEW O.N. (U5P) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of VIVANI MED.INC. NEW O.N. (2021–2025)
Cash flow-to-debt ratio of VIVANI MED.INC. NEW O.N. from 2021 to 2025. Historical debt coverage capacity for VIVANI MED.INC. NEW O.N. across 5 annual periods. Also explore VIVANI MED.INC. NEW O.N. (U5P) net asset momentum to track the company's year-over-year net asset growth rate.
VIVANI MED.INC. NEW O.N. Cash Flow-to-Debt Ratio by Year (2021–2025)
VIVANI MED.INC. NEW O.N. cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for VIVANI MED.INC. NEW O.N.. For the full cash flow conversion analysis, see VIVANI MED.INC. NEW O.N. (U5P) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.03x | €-24.32 Million | €23.66 Million | ▼ -18.4% |
| 2024 | -0.87x | €-20.79 Million | €23.95 Million | ▲ +8.3% |
| 2023 | -0.95x | €-23.70 Million | €25.04 Million | ▲ +65.6% |
| 2022 | -2.75x | €-18.79 Million | €6.82 Million | ▲ +24.9% |
| 2021 | -3.66x | €-10.95 Million | €2.99 Million | — |